title: VeroScience: applying nature's genius to help improve the human condition.
abstract: VeroScience is a biotechnology company in Tiverton, Rhode Island, focused on the development of therapies and products to improve human health. The company has a strong pipeline of metabolic disease products and therapies for immunological disorders. A major platform technology of the company, Circadian Neuroendocrine Resetting Therapy, is utilized as a generator of multiple therapeutic strategies to treat a variety of disease states. The circadian timed daily (morning) administration of Cycloset®, a quick release formulation of bromocriptine mesylate, a dopamine agonist, was developed for the treatment of type 2 diabetes using this platform technology.
mesh_terms: D001327:Autoimmune Diseases / Q000188:drug therapy; D001709:Biotechnology / Q000639:trends; D001971:Bromocriptine / Q000494:pharmacology*; D018491:Dopamine Agonists / Q000494:pharmacology*; D055808:Drug Discovery / Q000639:trends; D004345:Drug Industry / Q000639:trends*; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D008659:Metabolic Diseases / Q000188:drug therapy; D017448:Receptors, Dopamine D2 / Q000819:agonists; D012237:Rhode Island
chemical_list: D018491:Dopamine Agonists; D007004:Hypoglycemic Agents; D017448:Receptors, Dopamine D2; D001971:Bromocriptine
keywords: Neuroendrocrine Resetting Therapy; cycloset; glycemic control; type 2  diabetes